Administrators, staff and faculty at the College of Veterinary Medicine, together with officials from Blue Buffalo Company, gathered on Thursday, June 15 at the Veterinary Medical Center to celebrate the first year anniversary of the Blue Buffalo Veterinary Clinical Trials Office (BBVCTO) at Ohio State. In 2016, Blue Buffalo announced a $6 million gift to advance clinical trials at the college. The gift supports initiatives at the BBVCTO to conduct research to enhance medical knowledge and improve patient care for both animals and humans. The research studies focus on the development of new treatments for cancer, heart disease and arthritis.
“Our relationship with Ohio State is consistent with Blue Buffalo’s philosophy of giving back and supporting studies that advance veterinary medicine,” said Bill Bishop, company Founder and Chairman. “We are particularly happy to be associated with the OSU College of Veterinary Medicine because the innovative research of the Clinical Trials Office has the potential to positively impact both pet and human health.”
The Canine Oncology Trials Consortium study involves a new treatment to prevent metastasis in osteosarcoma, a serious type of bone cancer. The College of Veterinary Medicine entered more than 30 dogs with osteosarcoma into the study, one of the highest enrolling sites in the consortium.
“Given the complexities of the study, this would not have been possible without support from the Blue Buffalo Veterinary Clinical Trials Office,” said Cheryl London, DVM, PhD, Director of the Blue Buffalo Veterinary Clinical Trials Office and Research Professor at the Cummings School of Veterinary Medicine at Tufts. “Data generated from this trial will help advance the care of both humans and dogs with bone cancer.”
The Clinical Trials Office supervises research involving client-owned pets, and the pets continue to live with their owners during the study. Pet owners work with veterinary researchers during the trials with the ultimate goal of finding new therapies and diagnostics tests that will improve animal and human health.
“As an alumnus of The Ohio State University, I am proud to be part of the BLUE organization working closely with Dr. Cheryl London and her team at the Clinical Trials Office,” said Greg Reinhart, PhD, Senior VP of Research and Development at Blue Buffalo. “Our long-term partnership with Ohio State is off to a great start as we support clinical trials for a variety of diseases from cancer to heart failure.” The Blue Buffalo Foundation and the Petco Foundation recently raised more than $2.8 million nationwide during their Pet Cancer Awareness 2017 campaign. In addition to providing funding for pet cancer research, pet cancer treatment support funds are available for qualified pet owners through Ohio State and cancer treatment clinics and universities across the country.
These funds help pet owners pay for cancer treatments for their dogs, cats and other beloved pets. For more information about the BBVCTO, please visit http://vet.osu.edu/vmc/cto or watch the event coverage from NBC4i below.